Alzheimer's Disease Trial, Recruiting NCT06410157 Sponsor: University of Southern California Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06410157
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You speak and understand English fluently
  • You identify as Black/African-American or White/European-American
  • You are between 50 and 70 years old
  • You are not pregnant and have not had a menstrual period for at least the past year
  • You have normal vision and hearing, or vision and hearing that is fully corrected (for example, with glasses or hearing aids)
  • You have reliable access to a WiFi internet connection
  • You have an email account that you check on a regular basis
  • You have a phone that can receive text messages
  • You are willing to provide blood and urine samples at two visits to the study location
  • You are willing to spend up to 50 minutes per day on study activities for 10 weeks, plus attend two in-person visits

Who may not be able to join:

  • You have a condition that would make it difficult to do breathing exercises, such as an irregular heartbeat or difficulty breathing (confirm with trial site)
  • You have a problem with memory or thinking that affects your daily life
  • You have regularly played Lumosity brain-training games in the past 6 months
  • You have certain metal implants, devices, or objects in or on your body that make an MRI scan unsafe, including any of the following:
    • A cardiac pacemaker or implanted heart device
    • An aneurysm clip, neurostimulator, or other device implanted in your brain or nervous system
    • An insulin pump or other internal infusion device
    • A cochlear implant or other ear implant or tubes
    • An artificial limb, joint, or other implant held in place by a magnet
    • A heart valve replacement or other heart implant
    • Stents, filters, shunts, or catheters inside your body
    • An IUD (intrauterine device)
    • A skin patch (such as nicotine, birth control, or heart medication patches) that cannot be removed for the scan
    • Shrapnel, bullets, or metal fragments anywhere in your body
    • Tattooed eyeliner or eyebrows
    • Body piercings that cannot be removed for the scan
    • A wig, toupee, or hair implants involving staples or metal that cannot be removed for the scan
    • Hearing aids, dentures, or retainers that cannot be removed for the scan
    • Surgical staples, wire sutures, bone screws, pins, plates, or rods inside your body
    • Any other metal objects, implants, or electrodes in or on your body (confirm with trial site)
  • You have claustrophobia (fear of enclosed spaces)
  • You have ever worked in a job or hobby that involved grinding metal, or have had a metal injury to your eye

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 213-740-9543

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 January 2025
Est. completion
1 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in plasma amyloid-beta 42 levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov